Abbott Laboratories (ABTT34)
B3 Stock Exchange · Brazil · prices in BRL · close of 27 Oct 2026
Key indicators
| Last close | BRL 46.10 |
|---|---|
| 52-week range | 33.50 – 58.85 |
| Return, 1 month / 3 months | +5.0% / +3.6% |
| Return, 1 year / 3 years | −18.0% / +24.6% |
| Trend | Uptrend |
| RSI (14) | 58 |
| Volatility (1 year) | 41.6% |
| Worst drawdown (1 year) | -41.9% |
| Average daily value traded | 0.02M BRL |
| Dividend yield | 5.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Abbott Laboratories is a healthcare company based in the United States that makes a broad range of medical products. It produces infant formula and adult nutrition drinks, diagnostic tests and laboratory systems, and medical devices including heart stents and glucose monitoring sensors. It also makes generic medicines for emerging markets. Its customers are hospitals, clinics, laboratories, doctors and consumers who use its nutrition products, and it serves healthcare markets around the world.
Abbott Laboratories is represented on the B3 Stock Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code ABTT34, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Abbott Laboratories (ABTT34) trades on the B3 Stock Exchange in Brazil. It last closed at BRL 46.10 on 27 October 2026.
Its price-based Market X-Ray is 45 out of 100 (a weak price profile), ranking 889 of 1,455 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 18.0% and over the last three months it rose 3.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on B3 Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 52 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 5.8% | ||
| From 52-week high | -21.0% | ||
| Momentum | 48 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 3.6% | ||
| 6-month return | 19.9% | ||
| 12-month return, skipping the last month | -21.9% | ||
| Stability (higher is calmer) | 36 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 41.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -41.9% | ||
| Liquidity | 41 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.02M BRL | ||
| Zero-volume days | 3.3% | ||
| Income | 44 · Weak | Dividend is small or irregular. | |
| Dividend yield | 5.9% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | +7.1% |
|---|---|
| 1 month | +5.0% |
| 3 months | +3.6% |
| 6 months | +19.9% |
| 1 year | −18.0% |
| 3 years | +24.6% |
| 5 years | −16.9% |
Signals
| 50-day / 200-day average | 45.02 / 43.55 |
|---|---|
| Golden / death cross (60 days) | Golden, 29 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.49 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 13 Jul 2026 | USD 0.1848 |
| 13 Apr 2026 | USD 0.1779 |
| 13 Jan 2026 | USD 0.1858 |
| 13 Oct 2025 | USD 0.1774 |
| 11 Jul 2025 | USD 0.1801 |
| 11 Apr 2025 | USD 0.1893 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on B3 Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.